EOM 1352: Fri 7 June 2024, 11:36

Current Edition

Discovery Park: Wed 13 November 2024, 10:35
ramusmedical
news

FDA Solicits mHealth, Wearable Tech Info For Clinical Trials

The U.S. Food and Drug Administration (FDA) is seeking input from relevant stakeholders on how new technologies — including mobile health technology (mHealth), teleme...
Continue Reading →
Europe

Scottish Child Cancer Patients Missing out on Clinical Trials

CHILD cancer patients in Scotland are missing out on experimental treatments due to a lack of clinical trials, a study has found. Research presented at the National C...
Continue Reading →
news

CluePoints and Widler & Schiemann Collaborate on Complete Risk-Management Solution for Clinical Trials in Line with New Industry Guidance

Partnership will combine CluePoints' Risk-Based Monitoring Software with Widler & Schiemann's Consultancy Services 2 November 2015 Cambridge, MA - CluePoints, a l...
Continue Reading →
news

Macrocure (MCUR) Phase III Clinical Trial of CureXcell Missed Primary Endpoint

Macrocure Ltd. (NASDAQ: MCUR) today announced that results from a pivotal Phase 3 multicenter, randomized, double-blind, parallel-group, sham-controlled study (MC-102...
Continue Reading →
news

16 First Time Endovascular Clinical Trial Results to be presented at VIVA 15

LAS VEGAS, Oct. 27, 2015 /PRNewswire-USNewswire/ -- VIVA Physicians, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervent...
Continue Reading →
news

Science 37 Secures $6.5M Series A Funding To Accelerate Clinical Trial Research

LOS ANGELES, Oct. 20, 2015 /PRNewswire/ -- Science 37 (http://science37.com), a technology-enabled clinical research company, today announced the completion of a $6.5...
Continue Reading →
Europe

CATALENT WINS PRESTIGIOUS ‘INNOVATION IN PROCESS AND FORMULATION DEVELOPMENT’ AWARD AT CPHI WORLDWIDE FOR ITS OPTISHELL™ SOFTGEL TECHNOLOGY

Somerset, N.J. & CPhI Worldwide, Madrid, Spain – October 14, 2015 — Catalent Pharma Solutions (Stand 3G10), the leading global provider of advanced delivery tech...
Continue Reading →
Europe

Savolitinib Completes Enrolment for Phase II Clinical Trial in Papillary Renal Cell Carcinoma

Hutchison China MediTech Limited ("Chi-Med") (AIM: HCM) today announces that Hutchison MediPharma Limited ("HMP"), its drug R&D subsidiary, and AstraZeneca AB (pu...
Continue Reading →
Europe

First clinical trial to strengthen babies bones in the womb

The first clinical trial injecting foetal stem cells into babies still in the womb is to start in January. The research will attempt to treat those destined to be bo...
Continue Reading →
Asia Pacific

Latest Regulations on Pharmaceutical International Multi-Center Clinical Trials in China

For the first time in history, Chinese pharmaceutical authorities officially issued a guidance on international multi-center clinical trials of drugs in China, which ...
Continue Reading →
Catalyst: 12th January 2026
Quotient